Portugal vs Singapore: Estimated antiretroviral therapy coverage among people living with HIV
Portugal
89.0%
in 2023
Singapore
89.0%
in 2024
Portugal rank
22nd
Singapore rank
22nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Portugal
- Singapore
How they compare
Portugal currently reports 89.0% against 89.0% in Singapore, a difference of 0.0%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Portugal ahead.
Portugal ranks 22nd and Singapore ranks 22nd of 143 countries.
Across the 3 decades both report, Portugal averaged higher in 1 and Singapore in 2.
Head to head by decade
| Decade | Portugal | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.5% | 20.5% | 12.0% | Portugal |
| 2010s | 65.5% | 74.8% | 9.3% | Singapore |
| 2020s | 86.8% | 87.5% | 0.8% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Portugal or Singapore?
- Portugal, at 89.0% against 89.0% in Singapore as of 2023.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Portugal and Singapore?
- 0.0%, with Portugal ahead.
- How many years of comparable data are there for Portugal and Singapore?
- 24 years are reported by both, from 2000 to 2023.
- How do Portugal and Singapore rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Portugal ranks 22nd and Singapore ranks 22nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.